Drawing for C.

USPTO serial 97298868

C.

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ALTREE, NICHOLAS
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with C.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

B. Brett Heavner

B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP901 NEW YORK AVENUE NWWASHINGTON, DC 20001United States

Goods and services

ClassDescriptionStatusFirst use
005human pharmaceuticals for the treatment of pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions; infectious diseases, neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosinACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 27, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 27, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 24, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 23, 2025EX5GSOU EXTENSION 5 GRANTED—
Apr 1, 2025EXT5SOU EXTENSION 5 FILED—
Apr 1, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 17, 2025EX4GSOU EXTENSION 4 GRANTED—
Jan 9, 2025EXT4SOU EXTENSION 4 FILED—
Jan 9, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 22, 2024NOACCORRECTED NOA E-MAILED—
Nov 22, 2024DPCCDIVISIONAL PROCESSING COMPLETE—
Oct 24, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 20, 2024DRRRDIVISIONAL REQUEST RECEIVED—
Aug 20, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 20, 2024EX3GSOU EXTENSION 3 GRANTED—
Aug 20, 2024EXT3SOU EXTENSION 3 FILED—
Aug 20, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 12, 2024EX2GSOU EXTENSION 2 GRANTED—
Mar 12, 2024EXT2SOU EXTENSION 2 FILED—
Mar 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 9, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 7, 2023EX1GSOU EXTENSION 1 GRANTED—
Sep 7, 2023EXT1SOU EXTENSION 1 FILED—
Sep 7, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 19, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 17, 2022DOCKASSIGNED TO EXAMINER—
Mar 12, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance